Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prospective Double-Blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by University Hospital, Basel, Switzerland.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00861367
First received: March 12, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted

March 12, 2009
March 12, 2009
September 2008
December 2009   (final data collection date for primary outcome measure)
Blood loss [ Time Frame: intraoperative, 6 hours post op, 3 days postop ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
Reoperation rates [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Prospective Double-Blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
Prospektive Doppel-Blind-Randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Caregiver, Investigator)
Primary Purpose: Prevention
  • Blood Loss,Surgical;
  • Intraoperative Complications;
  • Reoperation Rates in Patients With Aspirin Treatment;
Drug: transurethral surgery with or without aspirin
aspirin 100mg once a day, transurethral surgery with or without aspirin
Other Name: Asprin cardio 100mg
  • Active Comparator: 1
    aspirin 100mg
    Intervention: Drug: transurethral surgery with or without aspirin
  • Placebo Comparator: 2
    empty capsule
    Intervention: Drug: transurethral surgery with or without aspirin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
124
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion Criteria:

  • Oral anticoagulation,
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00861367
05/08
No
Maurer Patrick/Dr., Department of Urology, Kantonsspital Liestal
University Hospital, Basel, Switzerland
Not Provided
Study Chair: thomas C Gasser, Prof Department of Urology, Liestal
University Hospital, Basel, Switzerland
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP